Neuroscience Trials Australia
- Country
- ๐ฆ๐บAustralia
- Ownership
- Private
- Established
- 2001-01-01
- Employees
- 51
- Market Cap
- -
Clinical Trials
12
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)โข Click on a phase to view related trials
DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval
- Conditions
- Ischemic Stroke
- First Posted Date
- 2018-04-11
- Last Posted Date
- 2022-06-16
- Lead Sponsor
- Neuroscience Trials Australia
- Target Recruit Count
- 295
- Registration Number
- NCT03494920
- Locations
- ๐ฆ๐บ
Liverpool Hospital, Liverpool, New South Wales, Australia
๐ฆ๐บJohn Hunter Hospital, New Lambton, New South Wales, Australia
๐ฆ๐บRoyal North Shore Hospital, St Leonards, New South Wales, Australia
STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units
- Conditions
- Intracerebral Haemorrhage
- Interventions
- Drug: Normal saline
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Neuroscience Trials Australia
- Target Recruit Count
- 201
- Registration Number
- NCT03385928
- Locations
- ๐ฆ๐บ
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
๐ฆ๐บLiverpool Hospital, Liverpool, New South Wales, Australia
๐ฆ๐บJohn Hunter Hospital, New Lambton Heights, New South Wales, Australia
Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Neuroscience Trials Australia
- Target Recruit Count
- 300
- Registration Number
- NCT03340493
- Locations
- ๐ฆ๐บ
Albury Hospital, Albury, New South Wales, Australia
๐ฆ๐บBankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia
๐ฆ๐บCampbelltown Hospital, Campbelltown, New South Wales, Australia
Trial of EXenatide in Acute Ischaemic Stroke
- First Posted Date
- 2017-09-19
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Neuroscience Trials Australia
- Target Recruit Count
- 350
- Registration Number
- NCT03287076
- Locations
- ๐ฆ๐บ
St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
๐ฆ๐บLiverpool Hospital, Liverpool, New South Wales, Australia
๐ฆ๐บSunshine Coast University Hospital, Birtinya, Queensland, Australia
Deferiprone to Delay Dementia (The 3D Study)
- Conditions
- Mild Cognitive ImpairmentProdromal Alzheimer's DiseaseMild Alzheimer's Disease
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-07-31
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Neuroscience Trials Australia
- Target Recruit Count
- 81
- Registration Number
- NCT03234686
- Locations
- ๐ฆ๐บ
KaRa Institute of Neurological Diseases, Macquarie Park, New South Wales, Australia
๐ฆ๐บHunter New England Local Health District, Waratah, New South Wales, Australia
๐ฆ๐บBox Hill Hospital, Box Hill, Victoria, Australia
- Prev
- 1
- 2
- 3
- Next